| The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery (NCT06680362) | xiaohua li | 2022-05-22 |
| Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Carcinoma (NCT05811546) | Assiut University | 2022-05-01 |
| Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer (NCT05229809) | Jie Li | 2022-03-01 |
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy (NCT05083338) | M.D. Anderson Cancer Center | 2021-08-10 |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer (NCT04505553) | University of Washington | 2021-06-01 |
| National Cancer Institute "Cancer Moonshot Biobank" (NCT04314401) | National Cancer Institute (NCI) | 2020-11-11 |
| The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer (NCT04602026) | Ohio State University Comprehensive Cancer Center | 2020-09-14 |
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma (NCT04443036) | China Medical University, China | 2020-06-11 |
| A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer (NCT04254107) | Seagen Inc. | 2020-05-29 |
| Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer (NCT03819088) | Emory University | 2019-04-17 |
| A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma (NCT03735511) | Henan Cancer Hospital | 2018-11-20 |
| XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma (NCT03599778) | Anhui Provincial Hospital | 2018-09-01 |
| XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma (NCT03355612) | Tianjin Medical University Cancer Institute and Hospital | 2017-12-20 |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia (NCT02782949) | National Cancer Institute (NCI) | 2017-04-04 |
| A Study Evaluating MM-310 in Patients With Solid Tumors (NCT03076372) | Merrimack Pharmaceuticals | 2017-02-22 |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors (NCT02611024) | PharmaMar | 2016-05-06 |
| CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor (NCT02617134) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2015-11-01 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer (NCT02409199) | Shanghai Zhongshan Hospital | 2015-06-01 |
| Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery (NCT02334332) | City of Hope Medical Center | 2015-01-01 |
| Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 (NCT02317471) | Chinese PLA General Hospital | 2014-11-01 |
| DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma (NCT02159339) | Peking University Cancer Hospital & Institute | 2012-12-01 |
| A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in China (NCT01812876) | China Academy of Chinese Medical Sciences | 2012-12-01 |
| Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma (NCT01642797) | Shandong University | 2012-08-01 |
| Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer (NCT01573468) | Genta Incorporated | 2012-04-01 |
| Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer (NCT00970138) | Fudan University | 2009-06-01 |
| Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma (NCT00639522) | Nanjing Sike Pharmaceutical Co., Ltd. | 2008-05-01 |
| Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma (NCT00256321) | University of California, Irvine | 2004-10-01 |